In the SURPASS trials, once weekly tirzepatide (515 mg) significantly reduced HbA1c (1.873.02%) and improved several cardiometabolic risk factors
Why this matters for creator-led brands generally Three implications for any creator running a CPG or supplement business
223 Pharmacokinetically, GLP-1RAs and GLP-1/GIP dual agonists display distinct profiles attributable to their structural heterogeneity, with extended half-lives potentially correlating with an increased risk of adverse events
Fatigue that won't quit deserves a real look
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
By targeting fat for energy, L-Carnitine supports a leaner physique and powers intense workouts without relying on muscle glycogen preserving glycogen stores for when they're specifically needed during high-intensity efforts, while fat handles the steady-state energy demand.